Medical Developments International Limited

A$0.40As of Sun 8 Nov 2026, 12:00 UTC
ASX:MVPHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (22.17%)
Div yield —
ROE 1.13%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.62
PE TTM 75.49
TSR TTM (42.86%)
Mkt cap A$45.06M
ROIC 6.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.479
19.80%
33.19%
Hold 6|11|7|3|5
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
(4.31%)
(9.82%)
(13.84%)
0.25%
Revenue$M
5.753
5.902
5.814
6.100
7.25%
4.63%
(1.24%)
6.58%
Peers (US$30.95M)
Cap (US$)
PE
24.27M
—
Capital
TTM
5Y
10Y
Leveragex
0.285
0.209
0.114
EBIT/Intx
1.176
0.171
0.164
Own earn%
26.15
(21.76)
(17.40)
Sh yield%
32.61
43.06
45.17
Owners
Insiders/Inst%
7.70
48.12
Short interest%
0.94
SBC / revenue%
2.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
3